J3245 HCPCS Level II code: Injection, tildrakizumab, 1 mg
J3245 is the HCPCS code for “Injection, tildrakizumab, 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J3245Injection, tildrakizumab, 1 mg
Short description: Inj., tildrakizumab, 1 mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J3245 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 2019
Where J3245 sits
- 1J codesDrugs administered other than orally
- 2Active code J3245Injection, tildrakizumab, 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J3245 mean?
J3245 is the HCPCS code for “Injection, tildrakizumab, 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J3245?
CMS lists J3245’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J3245
All J codesJ3150Injection, testosterone propionate, up to 100 mgJ3230Injection, chlorpromazine hcl, up to 50 mgJ3240Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vialJ3241Injection, teprotumumab-trbw, 10 mgJ3243Injection, tigecycline, 1 mgJ3244Injection, tigecycline (accord), not therapeutically equivalent to j3243, 1 mgJ3246Injection, tirofiban hcl, 0.25 mgJ3247Injection, secukinumab, intravenous, 1 mgJ3250Injection, trimethobenzamide hcl, up to 200 mgJ3260Injection, tobramycin sulfate, up to 80 mgJ3262Injection, tocilizumab, 1 mgJ3263Injection, toripalimab-tpzi, 1 mg